Clinical Trial Update: Corrected VA With Long-Term Follow-Up After AcrySof® Intraocular Lens (IOL) Implantation [NA]

View source ↗

Summary

This ClinicalTrials.gov update reports long-term corrected visual acuity outcomes after implantation of the AcrySof intraocular lens in pseudophakic eyes. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudophakia

Drugs mentioned

• AcrySof Intraocular Lens

Snippet

Sponsor: Alcon, a Novartis Company | Conditions: Pseudophakia | NA | Status: COMPLETED | Results posted: 2016-12-09